# Similar efficacy and safety of once‐weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/similar-efficacy-and-safety-of-once-weekly-dulaglutide-in-patients-with-type-2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Malaz Boustani,Isabella Pittman,Miao Yu,VT Thieu,Oralee J. Varnado,Rattan Juneja |
| Citations | 47 |
| DOI | 10.1111/dom.12687 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12687 |
| OpenAlex ID | https://openalex.org/W2466620119 |
| PMID | 27161178 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Oralee J. Varnado](https://scholariq.org/researchers/oralee-j-varnado/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.